Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)

v3.23.2
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Health plan receivable, allowance for credit loss $ 150 $ 0
Clinic fees, insurance and other receivable 1,937 7,500
Related Party    
Accounts payable, other 44,600 33,000
Variable Interest Entity, Primary Beneficiary    
Clinic fees, insurance and other receivable 114 1,178
Assets to settle obligations 10,600 3,100
Liabilities without recourse to company assets $ 14,500 $ 9,900
Class A Common Stock    
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized (in shares) 800,000,000 800,000,000
Common stock, shares issued (in shares) 114,098,000 41,579,000
Common stock, shares outstanding (in shares) 114,098,000 41,579,000
Class V Common Stock    
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized (in shares) 205,000,000 205,000,000
Common stock, shares issued (in shares) 198,505,000 201,592,000
Common stock, shares outstanding (in shares) 198,505,000 201,592,000